Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats two of the top 10 "priority pathogens" recently defined by the World Health Organization as antibiotic-resistant bacteria requiring new interventions. The[…]
A new study details the development of a blood test that can identify genetic mutations associated with nonsmall cell lung cancer within 72 hours. Researchers say that the test could lead to faster, more effective treatment for the disease.
An experimental immune-system therapy appears safe for people with progressive forms of multiple sclerosis. And it may ease symptoms in some, a preliminary study suggests.The findings are based on just six patients, and the Australian researchers stressed that a lot[…]